Before submitting to our online submission system, please carefully check that your manuscript has been prepared in accordance with the step-by-step instructions. The guide and the EnPress Manuscript Submission Template

Your manuscript should be in the MS Word format. You are advised to follow the new manuscript template for more details for preparing your submissions to Characterization and Application of Nanomaterials for consideration.
All manuscripts must be written in clear, comprehensible English. Both British and American English are accepted. The usage of non-English words should be kept to a minimum. If you have concerns about the level of English in your manuscript, please ensure that it is proofread by a native English speaker or a scientific editing service before submission.

Before submitting to our online submission system, please carefully check that your manuscript has been prepared in accordance with the step-by-step instructions. The guide and the EnPress Manuscript Submission Template

Before submitting to our online submission system, please carefully check that your manuscript has been prepared in accordance with the step-by-step instructions. The guide and the EnPress Manuscript Submission Template

Your manuscript should be in the MS Word format. You are advised to follow the new manuscript template for more details for preparing your submissions to Characterization and Application of Nanomaterials for consideration.
All manuscripts must be written in clear, comprehensible English. Both British and American English are accepted. The usage of non-English words should be kept to a minimum. If you have concerns about the level of English in your manuscript, please ensure that it is proofread by a native English speaker or a scientific editing service before submission.

Before submitting to our online submission system, please carefully check that your manuscript has been prepared in accordance with the step-by-step instructions. The guide and the EnPress Manuscript Submission Template

Your manuscript should be in the MS Word format. You are advised to follow the new manuscript template for more details for preparing your submissions to Characterization and Application of Nanomaterials for consideration.
All manuscripts must be written in clear, comprehensible English. Both British and American English are accepted. The usage of non-English words should be kept to a minimum. If you have concerns about the level of English in your manuscript, please ensure that it is proofread by a native English speaker or a scientific editing service before submission.

Authorship of a scholarly paper should be limited to individuals who have contributed substantially to its intellectual content. Participation solely in the acquisition of funding or general supervision of the research group is not sufficient for authorship. All authors should hold the responsibility of fairly evaluating their respective roles and their co-authors’ roles in the project. This is to ensure that authorship is attributed according to a fixed standard in all publications for which they will be listed as authors. You are recommended to refer to the definition of authorship and contributors carefully in ICMJE, and Contributor Roles Taxonomy (CRediT).

In order to be listed as an author for a paper, one should have contributed sufficiently in the project. A co-author is expected to have contributed to some component of the work which led to the paper, or be involved in interpretation of its results. All authors should have a say in the final approval of the version to be published, in addition to reviewing the final manuscript prior to submission.

Individuals who do not meet the above requirements, but have provided a valuable contribution to the work, may be acknowledged for their contribution as appropriate to the publication.

Changes to Authorship

The authors should carefully check the list and order of authors before submitting their manuscript. The Editorial Office considers the authorship list is definitive by the time the original submission is received.

Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript is accepted for publication. The corresponding author should provide the reasons for the change in authorship list and the proof of written confirmation from all authors (including the existing authors, author(s) to be added and/or removed) agreeing with such change, to the Editorial Office.

The requests for authorship changes need to be approved by the Editorial Office before any changes can be made.

Conflicts of interest may exist when professional judgements concerning a primary interest has the possibility of being influenced by a secondary interest (e.g.: financial gains). It is to be noted that even perceptions of conflicts of interest are as important as the actual conflicts of interest.

Any agreements with study sponsors (for profit or non-profit), which interfere with the authors’ access to the study data, ability to analyse or interpret the data and publish manuscripts independently according to their own decision, should be avoided by authors at all costs.

A declaration of interests for all authors should be received before an article can be reviewed and accepted for publication.

For authors:

While submitting, authors must list all competing interests relevant to this work, including but not limited to:

♢ Funding sources

♢ The role of sponsors in the work design, data collection, and results of the analysis.

♢ Whether any of the authors serves on the Editorial Board of the journal that they are submitting their article to.

For editors and reviewers:

Editors and reviewers must declare any possible conflict of interests in connection with the manuscript, and if necessary, they must withdraw the peer review process. When Editorial Board Members publish articles in the served journal, the editorial office will actively emphasize it so that the authors know that they recuse the potential peer review process.

Common reasons for editors and reviewers to be replaced include but are not limited to:

♢ The editor or reviewer works at the same organization as one of the authors.

♢ The editor or reviewer is one of the authors of this work.

♢ The editor or reviewer is on the avoidance list from the author(s).

♢ The editor or reviewer has a financial or personal relationship with an author.

EnPress Publisher publishes all its journals in Gold Open Access format. The scientific community and the general public have free of all restrictions on accessing (e.g., subscription) and free of many restrictions on using its contents as soon as it is published online. Enpress does not require readers to purchase any form of subscription to view online versions of the journals. In order to defray our editorial and production costs, authors of the accepted articles are required to pay the article processing charges (APCs). The charges will come from authors' institutes or research funding bodies.

Waiver Policy

CAN is committed to promoting the academic development in the world without any financial barrier to knowledge sharing and learning. There has developed a waiver/discount policy especially for authors from low-income countries. Authors who are interested in applying for a waiver/discount could contact can.office@enpress-publisher.com. CAN reserves the right to approve or reject a waiver application. APC waivers do not influence editorial decisions.

Characterization and Application of Nanomaterials is indexed, cataloged and/or included by several world-class abstracting/indexing databases:

Scopus

CAS

ROAD

CNKI Scholar 

Crossref

Google Scholar

Scilit

Worldcat

J-Gate

♢ All the articles published online will be archived by Portico for long-term digital preservation.

♢ Authors are encouraged to self-archive the final version of their published articles into institutional repositories (such as those listed in the  Directory of Open Access Repositories).

♢ Authors are also encouraged to use the final PDF version published on the website of EnPress Publisher, LLC.

EnPress Publisher complies with the Data and reproducibility of COPE, encourages the use of discipline’s standard practice and guidelines. For clinical trials, they should register in corresponding approval institute or repository. EnPress encourages authors to reposit the raw dataset in community repository if the dataset is not available as the supplementary material. Authors having reported a data repository, are encouraged to add a statement of data availability in their manuscript, which may involve the availability of the research data and potential limitations, such as human privacy or biosecurity. All the data is crucial for the replicability, transparency, and credibility of scientific findings.

Data sharing

Authors are encouraged to follow the FAIR Data Principles, which guides that all the (meta)data should be assigned a unique persistent identifier. Journal office has the right to ensure and review the credibility of the dataset, and the possibility of collaborative investigations with institutions exists to ensure the scientific credibility of this scientific research practice. EnPress Publisher strict adheres to the unpublished and published data guidelines of COPE, and the corresponding author must response each inquiry. If there is major issue on dataset, a manuscript may be rejected.

Data citation

Dataset should be cited in the manuscript/article to give creators’ credit. The original source should be listed in the reference section, such as the author(s), publishing year, repository/archive name, dataset’s DOI.

Data repository

Authors are encouraged to share your dataset in the discipline repository, and authors could find an appropriate subject dataset repository with a registered DOI from FAIRsharing.org and re3data.org.

Authors also could deposit the datasets in a general dataset repository, such as those provided by a university, sponsor of institution. Below are some examples of generalized dataset repositories:

♢ Open Science Framework

♢ Dryad Digital Repository

♢ Figshare

♢ Harvard Dataverse

♢ Zenodo

♢ Science Data Bank